Dimed S.A. Distribuidora de Medicamentos (BVMF:PNVL3)
Brazil · Delayed Price · Currency is BRL 11.54
+0.14 (1.23%)
Jun 2, 2026, 10:55 AM GMT-3
BVMF:PNVL3 Cash Flow Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 132.37 | 124.61 | 105.51 | 92.91 | 86.35 | 79.43 |
Depreciation & Amortization | 204.86 | 207.27 | 210.2 | 200.15 | 184.57 | 157.77 |
Other Amortization | 31.23 | 23.92 | - | - | - | - |
Asset Writedown & Restructuring Costs | 5.06 | 4.7 | 6.56 | 6.41 | 2.18 | 3.47 |
Stock-Based Compensation | 7.06 | 6.9 | 6.03 | 5.61 | - | - |
Provision & Write-off of Bad Debts | -2.08 | -3.02 | 1.37 | 0.11 | 1.11 | 0.38 |
Other Operating Activities | 125.29 | 109.15 | 109.26 | 63.38 | 35.51 | -1.45 |
Change in Accounts Receivable | -88.59 | -126.46 | 5.94 | -52.95 | -76.14 | -38.89 |
Change in Inventory | -225.6 | -15.27 | -151.19 | -103.01 | -157.64 | -164.46 |
Change in Accounts Payable | 223.74 | 94.48 | -48.94 | 124.31 | 89.04 | 90.45 |
Change in Income Taxes | 29.05 | 9.24 | 4.71 | 15.41 | 15.76 | 9.75 |
Change in Other Net Operating Assets | 11.29 | 37.59 | -25 | -55.71 | 24.74 | -5.28 |
Operating Cash Flow | 450.77 | 473.1 | 224.45 | 296.62 | 205.48 | 131.18 |
Operating Cash Flow Growth | 46.35% | 110.78% | -24.33% | 44.35% | 56.64% | 0.15% |
Capital Expenditures | -118.22 | -122.15 | -122.72 | -114.42 | -149.3 | -110.05 |
Sale (Purchase) of Intangibles | -36.67 | -37.94 | -35.1 | -25.02 | -32.34 | -25.54 |
Investment in Securities | -134.83 | -223.26 | 102.13 | -57.12 | 39.07 | 150.49 |
Other Investing Activities | - | - | - | - | 11.48 | - |
Investing Cash Flow | -286.72 | -383.35 | -55.69 | -196.56 | -131.09 | 14.91 |
Long-Term Debt Issued | - | 281.28 | 281.73 | 425 | 150 | - |
Long-Term Debt Repaid | - | -323.16 | -318.39 | -453.94 | -203.17 | -175.3 |
Net Debt Issued (Repaid) | -140.75 | -41.88 | -36.66 | -28.94 | -53.17 | -175.3 |
Issuance of Common Stock | 1.91 | 1.91 | 1.93 | 2.08 | 1.45 | 0.68 |
Repurchase of Common Stock | -8.06 | -7.78 | -4.93 | -0.72 | -1.61 | -20.41 |
Common Dividends Paid | -28.51 | -26.46 | -33.17 | -28.72 | -24.75 | -20.44 |
Other Financing Activities | -59.61 | -51.81 | -43.89 | -41.53 | -25.04 | -6.29 |
Financing Cash Flow | -235 | -126.01 | -116.71 | -97.83 | -103.12 | -221.76 |
Net Cash Flow | -70.95 | -36.25 | 52.04 | 2.24 | -28.72 | -75.67 |
Free Cash Flow | 332.55 | 350.95 | 101.73 | 182.2 | 56.18 | 21.13 |
Free Cash Flow Growth | 86.22% | 245.00% | -44.17% | 224.31% | 165.85% | -68.50% |
Free Cash Flow Margin | 5.83% | 6.37% | 2.06% | 4.08% | 1.41% | 0.66% |
Free Cash Flow Per Share | 2.21 | 2.34 | 0.68 | 1.22 | 0.38 | 0.14 |
Cash Interest Paid | 59.61 | 51.81 | 43.89 | 41.53 | 25.04 | 6.29 |
Cash Income Tax Paid | 5.62 | 10.72 | 10.31 | 3.56 | 4.66 | 4.7 |
Levered Free Cash Flow | 148.32 | 186.93 | -63.9 | 39.68 | -54.03 | -69.32 |
Unlevered Free Cash Flow | 237.14 | 270.64 | 1.65 | 103.79 | -10.27 | -46.12 |
Change in Working Capital | -50.11 | -0.41 | -214.48 | -71.95 | -104.24 | -108.43 |